A (b)(6)-year old female patient with newly diagnosed glioblastoma (gbm) began optune therapy on (b)(6) 2020.Novocure received a report on (b)(6) 2022, that the patient reportedly experienced a skin irritation and a wound on her head.On (b)(6) 2022, it was reported that the patient had been hospitalized on an unspecified date for five days due to worsened skin irritation/wound on the forehead.No further information provided.Patient continued with optune therapy.After several attempts of contact, prescribing physician did not reply with any additional information or causality assessment.
|